Wed, July 26, 2023
Tue, July 25, 2023
Mon, July 24, 2023

Gregory Renza Maintained (VRCA) at Buy with Increased Target to $14 on, Jul 25th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-14-on-jul-25th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gregory Renza of RBC Capital, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Buy with Increased Target from $11 to $14 on, Jul 25th, 2023.

Gregory has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Gregory's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gregory


  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Monday, July 17th, 2023

Publication Contributing Sources